CollPlant Biotechnologies CLGN Estimates

NASDAQ CLGN
$3.41 -0.17 (-4.75%)
At close: Sep 9, 2026 · 4:00 PM EDT
Analyst Estimates

CollPlant Biotechnologies Ltd Revenue Estimates

Periods 12
Next Period Q4 25
Consensus 2.15 M

Analysts expect CollPlant Biotechnologies Ltd to report revenue of 2.15 M for Q4 25, against a range of 1.94 M to 2.36 M. The most recent reported quarter, Q1 26, came in at 73,000.00, a 84.6% miss against the 474,973.00 consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27
Reported (Actual) 249,000.004,000.00165,000.002.06 M179,000.0077,000.00-73,000.00----
High Estimate 391,671.75469,919.03113,548.762.87 M2.60 M5.34 M2.36 M514,763.39487,355.43537,421.12519,624.68658,065.03
Low Estimate 356,855.51389,054.4192,923.242.60 M2.33 M4.87 M1.94 M435,182.61407,388.57459,715.28486,163.12550,009.97
Consensus Estimate 374,263.63429,486.72103,236.002.74 M2.46 M5.11 M2.15 M474,973.00447,372.00498,568.20502,893.90604,037.50
Analyst Estimates

CollPlant Biotechnologies Ltd Earnings Per Share (EPS) Estimates

Periods 27
Next Period Q4 25
Consensus -0.28

Analysts expect CollPlant Biotechnologies Ltd to report earnings per share of -0.28 for Q4 25, against a range of -0.31 to -0.25. The most recent reported quarter, Q1 26, came in at -0.23, a 8.0% beat against the -0.25 consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -0.37-0.38-0.33-0.13-0.28-0.27--0.23-------
High Estimate -0.26-0.25-0.11-0.04-0.080.16-0.25-0.23-0.20-0.05-0.05-0.04-0.140.010.05
Low Estimate -0.30-0.29-0.13-0.04-0.100.14-0.31-0.27-0.24-0.05-0.05-0.04-0.160.010.05
Consensus Estimate -0.28-0.27-0.12-0.04-0.090.15-0.28-0.25-0.22-0.05-0.05-0.04-0.150.010.05